Literature DB >> 31988436

Depression phenotype identified by using single nucleotide exact amplicon sequence variants of the human gut microbiome.

Bruce R Stevens1,2,3, Luiz Roesch4,5, Priscila Thiago4, Jordan T Russell4, Carl J Pepine6, Richard C Holbert7, Mohan K Raizada8, Eric W Triplett4.   

Abstract

Single nucleotide exact amplicon sequence variants (ASV) of the human gut microbiome were used to evaluate if individuals with a depression phenotype (DEPR) could be identified from healthy reference subjects (NODEP). Microbial DNA in stool samples obtained from 40 subjects were characterized using high throughput microbiome sequence data processed via DADA2 error correction combined with PIME machine-learning de-noising and taxa binning/parsing of prevalent ASVs at the single nucleotide level of resolution. Application of ALDEx2 differential abundance analysis with assessed effect sizes and stringent PICRUSt2 predicted metabolic pathways. This multivariate machine-learning approach significantly differentiated DEPR (n = 20) vs. NODEP (n = 20) (PERMANOVA P < 0.001) based on microbiome taxa clustering and neurocircuit-relevant metabolic pathway network analysis for GABA, butyrate, glutamate, monoamines, monosaturated fatty acids, and inflammasome components. Gut microbiome dysbiosis using ASV prevalence data may offer the diagnostic potential of using human metaorganism biomarkers to identify individuals with a depression phenotype.
© 2020. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31988436     DOI: 10.1038/s41380-020-0652-5

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  24 in total

1.  Half-of-the sites reactivity in the catalytic mechanism of yeast glyceraldehyde 3-phosphate dehydrogenase.

Authors:  W B Stallcup; D E Koshland
Journal:  J Mol Biol       Date:  1973-10-15       Impact factor: 5.469

2.  [Controlled clinical trials of a new appetite-inhibiting drug].

Authors:  G Bani; C Barba; G Ricci
Journal:  Clin Ter       Date:  1968-10-31

3.  Synovial fluid inhibits killing of Staphylococcus aureus by neutrophils.

Authors:  G L Simon; H G Miller; D G Borenstein
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Use of computers in studying quality of care.

Authors:  P L Miller; T J Berry
Journal:  QRB Qual Rev Bull       Date:  1980-05

5.  The effect of cephaloridine on renal function in patients with renal failure.

Authors:  P E Gower
Journal:  Postgrad Med J       Date:  1967-08       Impact factor: 2.401

6.  [Clinical evaluation of serum and urinary proline and hydroxyproline determination in thyroid diseases].

Authors:  M Eisner; A Kondraciuk
Journal:  Pol Arch Med Wewn       Date:  1967

7.  On the etiology and pathogenesis of porotic hyperostosis of the skull.

Authors:  D J Ponec; D Resnick
Journal:  Invest Radiol       Date:  1984 Jul-Aug       Impact factor: 6.016

8.  Relationship between the in-situ activity of ornithine decarboxylase and contractile function of the rabbit papillary muscle.

Authors:  R J Boucek; R D Olson; R C Boerth
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

9.  Antigen-specific lymphocyte transformation in patients with recent yersiniosis.

Authors:  R Vuento
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-04

10.  Host-dependent transposon Tn5-mediated streptomycin resistance.

Authors:  G F De Vos; T M Finan; E R Signer; G C Walker
Journal:  J Bacteriol       Date:  1984-07       Impact factor: 3.490

View more
  14 in total

1.  Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.

Authors:  Eva M Medina-Rodriguez; Derik Madorma; Gregory O'Connor; Brittany L Mason; Dongmei Han; Sapna K Deo; Mark Oppenheimer; Charles B Nemeroff; Madhukar H Trivedi; Sylvia Daunert; Eléonore Beurel
Journal:  Am J Psychiatry       Date:  2020-07-31       Impact factor: 18.112

2.  The Gut Microbiome as a Component of the Gut-Brain Axis in Cognitive Health.

Authors:  Wen Gao; Kelley L Baumgartel; Sheila A Alexander
Journal:  Biol Res Nurs       Date:  2020-07-17       Impact factor: 2.522

3.  The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder.

Authors:  Tom Knuesel; M Hasan Mohajeri
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

Review 4.  Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome.

Authors:  Eline Margrete Randulff Hillestad; Aina van der Meeren; Bharat Halandur Nagaraja; Ben René Bjørsvik; Noman Haleem; Alfonso Benitez-Paez; Yolanda Sanz; Trygve Hausken; Gülen Arslan Lied; Arvid Lundervold; Birgitte Berentsen
Journal:  World J Gastroenterol       Date:  2022-01-28       Impact factor: 5.742

5.  The effect of interventions targeting gut microbiota on depressive symptoms: a systematic review and meta-analysis.

Authors:  Mark Hofmeister; Fiona Clement; Scott Patten; Joyce Li; Laura E Dowsett; Brenlea Farkas; Liza Mastikhina; Oluwaseun Egunsola; Ruth Diaz; Noah C A Cooke; Valerie H Taylor
Journal:  CMAJ Open       Date:  2021-12-21

6.  Assessing the effect of interaction between C-reactive protein and gut microbiome on the risks of anxiety and depression.

Authors:  Yujing Chen; Peilin Meng; Shiqiang Cheng; Yumeng Jia; Yan Wen; Xuena Yang; Yao Yao; Chuyu Pan; Chun'e Li; Huijie Zhang; Jingxi Zhang; Zhen Zhang; Feng Zhang
Journal:  Mol Brain       Date:  2021-09-04       Impact factor: 4.041

7.  Faecal microbiota transplantation from patients with depression or healthy individuals into rats modulates mood-related behaviour.

Authors:  Julie Kristine Knudsen; Thomas Yssing Michaelsen; Caspar Bundgaard-Nielsen; René Ernst Nielsen; Simon Hjerrild; Peter Leutscher; Gregers Wegener; Suzette Sørensen
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

8.  Improved detection of disease-associated gut microbes using 16S sequence-based biomarkers.

Authors:  Brianna S Chrisman; Kelley M Paskov; Nate Stockham; Jae-Yoon Jung; Maya Varma; Peter Y Washington; Christine Tataru; Shoko Iwai; Todd Z DeSantis; Maude David; Dennis P Wall
Journal:  BMC Bioinformatics       Date:  2021-10-19       Impact factor: 3.307

Review 9.  Gut Microbiome in Psoriasis: An Updated Review.

Authors:  Mariusz Sikora; Albert Stec; Magdalena Chrabaszcz; Aleksandra Knot; Anna Waskiel-Burnat; Adriana Rakowska; Malgorzata Olszewska; Lidia Rudnicka
Journal:  Pathogens       Date:  2020-06-12

Review 10.  Gut microbiota variations in patients diagnosed with major depressive disorder-A systematic review.

Authors:  Julie Kristine Knudsen; Caspar Bundgaard-Nielsen; Simon Hjerrild; René Ernst Nielsen; Peter Leutscher; Suzette Sørensen
Journal:  Brain Behav       Date:  2021-05-28       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.